When there will never be a randomized controlled trial

作者:Scialla Julia J; Wolf Myles
来源:Kidney International, 2015, 88(2): 220-222.
DOI:10.1038/ki.2015.123

摘要

There are many unanswered questions about how to manage secondary hyperparathyroidism and associated alterations in mineral metabolism in patients with end-stage renal disease. We provide commentary on an observational study by Komaba et al. that presents interesting new insights into the long-standing controversy related to the impact of parathyroidectomy on survival of hemodialysis patients.